메뉴 건너뛰기




Volumn 104, Issue 4, 2009, Pages 548-553

Correlation of Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol With Apolipoprotein B During Simvastatin + Fenofibrate Therapy in Patients With Combined Hyperlipidemia (A Subanalysis of the SAFARI Trial)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FENOFIBRATE; INTERMEDIATE DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

EID: 67849117308     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.018     Document Type: Article
Times cited : (35)

References (30)
  • 1
    • 0037126729 scopus 로고    scopus 로고
    • Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 3
    • 44649098307 scopus 로고    scopus 로고
    • Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology foundation
    • Brunzell J.D., Davidson M., Furberg C.D., Goldberg R.B., Howard B.V., Stein J.H., and Witztum J.L. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology foundation. Diab Care 31 (2008) 811-822
    • (2008) Diab Care , vol.31 , pp. 811-822
    • Brunzell, J.D.1    Davidson, M.2    Furberg, C.D.3    Goldberg, R.B.4    Howard, B.V.5    Stein, J.H.6    Witztum, J.L.7
  • 4
    • 0037069339 scopus 로고    scopus 로고
    • Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
    • Grundy S.M. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106 (2002) 2526-2529
    • (2002) Circulation , vol.106 , pp. 2526-2529
    • Grundy, S.M.1
  • 5
    • 0842285784 scopus 로고    scopus 로고
    • Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management
    • Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., and Kahn R.A. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
    • (2004) Circulation , vol.109 , pp. 551-556
    • Grundy, S.M.1    Hansen, B.2    Smith Jr., S.C.3    Cleeman, J.I.4    Kahn, R.A.5
  • 6
    • 35048827381 scopus 로고    scopus 로고
    • Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome
    • Clarenbach J.J., Grundy S.M., Palacio N., and Vega G.L. Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome. J Invest Med 55 (2007) 237-247
    • (2007) J Invest Med , vol.55 , pp. 237-247
    • Clarenbach, J.J.1    Grundy, S.M.2    Palacio, N.3    Vega, G.L.4
  • 8
    • 0242490858 scopus 로고    scopus 로고
    • Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update
    • Genest J., Frohlich J., Fodor G., and McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Can Med Assoc J 169 (2003) 921-924
    • (2003) Can Med Assoc J , vol.169 , pp. 921-924
    • Genest, J.1    Frohlich, J.2    Fodor, G.3    McPherson, R.4
  • 9
    • 23044485065 scopus 로고    scopus 로고
    • Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
    • Liu J., Sempos C., Donahue R.P., Dorn J., Trevisan M., and Grundy S.M. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diab Care 28 (2005) 1916-1921
    • (2005) Diab Care , vol.28 , pp. 1916-1921
    • Liu, J.1    Sempos, C.2    Donahue, R.P.3    Dorn, J.4    Trevisan, M.5    Grundy, S.M.6
  • 10
    • 27744452965 scopus 로고    scopus 로고
    • Non-high-density lipoprotein cholesterol: the forgotten therapeutic target
    • Maki K.C., Galant R., and Davidson M.H. Non-high-density lipoprotein cholesterol: the forgotten therapeutic target. Am J Cardiol 96 (2005) 59K-64K
    • (2005) Am J Cardiol , vol.96
    • Maki, K.C.1    Galant, R.2    Davidson, M.H.3
  • 12
    • 3042743500 scopus 로고    scopus 로고
    • Non-HDL cholesterol as a measure of atherosclerotic risk
    • Packard C.J., and Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 11 (2004) 6-14
    • (2004) J Atheroscler Thromb , vol.11 , pp. 6-14
    • Packard, C.J.1    Saito, Y.2
  • 15
    • 27744444803 scopus 로고    scopus 로고
    • Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B
    • Stein E.A., Sniderman A., and Laskarzewski P. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B. Am J Cardiol 96 (2005) 36K-43K
    • (2005) Am J Cardiol , vol.96
    • Stein, E.A.1    Sniderman, A.2    Laskarzewski, P.3
  • 16
    • 0038402528 scopus 로고    scopus 로고
    • Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
    • Sniderman A.D., Pierre A.C., Cantin B., Dagenais G.R., Despres J.P., and Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol 91 (2003) 1173-1177
    • (2003) Am J Cardiol , vol.91 , pp. 1173-1177
    • Sniderman, A.D.1    Pierre, A.C.2    Cantin, B.3    Dagenais, G.R.4    Despres, J.P.5    Lamarche, B.6
  • 17
    • 33644873843 scopus 로고    scopus 로고
    • Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
    • Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., and Rimm E.B. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112 (2005) 3375-3383
    • (2005) Circulation , vol.112 , pp. 3375-3383
    • Pischon, T.1    Girman, C.J.2    Sacks, F.M.3    Rifai, N.4    Stampfer, M.J.5    Rimm, E.B.6
  • 18
    • 14944342962 scopus 로고    scopus 로고
    • Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men
    • Simon A., Chironi G., Gariepy J., Del Pino M., and Levenson J. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis 179 (2005) 339-344
    • (2005) Atherosclerosis , vol.179 , pp. 339-344
    • Simon, A.1    Chironi, G.2    Gariepy, J.3    Del Pino, M.4    Levenson, J.5
  • 19
    • 0035423181 scopus 로고    scopus 로고
    • Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels
    • Ballantyne C.M., Andrews T.C., Hsia J.A., Kramer J.H., and Shear C. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels. Am J Cardiol 88 (2001) 265-269
    • (2001) Am J Cardiol , vol.88 , pp. 265-269
    • Ballantyne, C.M.1    Andrews, T.C.2    Hsia, J.A.3    Kramer, J.H.4    Shear, C.5
  • 20
    • 48849112223 scopus 로고    scopus 로고
    • Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients-the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY II) trial
    • Ballantyne C.M., Raichlen J.S., and Cain V.A. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients-the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY II) trial. J Am Coll Cardiol 52 (2008) 626-632
    • (2008) J Am Coll Cardiol , vol.52 , pp. 626-632
    • Ballantyne, C.M.1    Raichlen, J.S.2    Cain, V.A.3
  • 21
    • 0033956848 scopus 로고    scopus 로고
    • Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
    • LeRoux G., Lemieux I., Lamarche B., Cantin B., Dagenais G.R., Lupien P.J., and Despres J.P. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels. Metabolism 49 (2000) 53-61
    • (2000) Metabolism , vol.49 , pp. 53-61
    • LeRoux, G.1    Lemieux, I.2    Lamarche, B.3    Cantin, B.4    Dagenais, G.R.5    Lupien, P.J.6    Despres, J.P.7
  • 23
    • 13844272245 scopus 로고    scopus 로고
    • Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
    • Grundy S.M., Vega G.L., Yuan Z., Battisti W.P., Brady W.E., and Palmisano J. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial). Am J Cardiol 95 (2005) 462-468
    • (2005) Am J Cardiol , vol.95 , pp. 462-468
    • Grundy, S.M.1    Vega, G.L.2    Yuan, Z.3    Battisti, W.P.4    Brady, W.E.5    Palmisano, J.6
  • 24
    • 0023461362 scopus 로고
    • An international collaborative study on standardization of apolipoprotein A-I and apolipoprotein B: part I. Evaluation of a lyophilized candidate reference and calibration material
    • Smith S.J., Cooper G.R., Henderson L.O., and Hannon W.H. An international collaborative study on standardization of apolipoprotein A-I and apolipoprotein B: part I. Evaluation of a lyophilized candidate reference and calibration material. Clin Chem 33 (1987) 2240-2249
    • (1987) Clin Chem , vol.33 , pp. 2240-2249
    • Smith, S.J.1    Cooper, G.R.2    Henderson, L.O.3    Hannon, W.H.4
  • 25
    • 0022885505 scopus 로고
    • Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B
    • Young S.G., Smith R.S., Hogle D.M., Curtiss L.K., and Witztum J.L. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem 32 (1986) 1484-1490
    • (1986) Clin Chem , vol.32 , pp. 1484-1490
    • Young, S.G.1    Smith, R.S.2    Hogle, D.M.3    Curtiss, L.K.4    Witztum, J.L.5
  • 26
    • 22244446183 scopus 로고    scopus 로고
    • Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
    • Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
    • (2005) JAMA , vol.294 , pp. 326-333
    • Ridker, P.M.1    Rifai, N.2    Cook, N.R.3    Bradwin, G.4    Buring, J.E.5
  • 28
    • 0023850471 scopus 로고
    • Comparison of commercial kits for apoprotein-A-I and apoprotein-B with standardized apoprotein-A-I and B radioimmunoassays performed at the Northwest Lipid Research Center
    • Albers J.J., and Adolphson J.L. Comparison of commercial kits for apoprotein-A-I and apoprotein-B with standardized apoprotein-A-I and B radioimmunoassays performed at the Northwest Lipid Research Center. J Lipid Res 29 (1988) 102-108
    • (1988) J Lipid Res , vol.29 , pp. 102-108
    • Albers, J.J.1    Adolphson, J.L.2
  • 29
    • 0033624053 scopus 로고    scopus 로고
    • Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry
    • Beghin L., Duhal N., Poulain P., Hauw P., Lacroix B., Lecerf J.M., Bonte J.P., Fruchart J.C., and Luc G. Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry. J Lipid Res 41 (2000) 1172-1176
    • (2000) J Lipid Res , vol.41 , pp. 1172-1176
    • Beghin, L.1    Duhal, N.2    Poulain, P.3    Hauw, P.4    Lacroix, B.5    Lecerf, J.M.6    Bonte, J.P.7    Fruchart, J.C.8    Luc, G.9
  • 30
    • 0028179990 scopus 로고
    • International Federation of Clinical Chemistry standardization project for measurements of apolipoprotein-A-I and apolipoprotein-B. Part IV. Comparability of apolipoprotein-B values by use of international reference material
    • Marcovina S.M., Albers J.J., Kennedy H., Mei J.V., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry standardization project for measurements of apolipoprotein-A-I and apolipoprotein-B. Part IV. Comparability of apolipoprotein-B values by use of international reference material. Clin Chem 40 (1994) 586-592
    • (1994) Clin Chem , vol.40 , pp. 586-592
    • Marcovina, S.M.1    Albers, J.J.2    Kennedy, H.3    Mei, J.V.4    Henderson, L.O.5    Hannon, W.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.